aod9604 effect on blood sugar Does peptide demonstrate effective fat loss in humans? AOD 9604 Peptide Therapy Victoria

Progress Photos: Standardized photos (same lighting, angles, clothing) every 2-4 weeks document visual changes that measurements may miss

Not intended for human consumption, injection, or cosmetic use

A 2025 study in Biomolecules found that NNMT inhibitor treatment "reduces body weight, white adipose tissue mass, total cholesterol, and adipocyte size in obese mice." These changes suggest cardiovascular benefit beyond simple weight loss

This tracking helps ensure you're rotating sites properly, which prevents tissue damage

preserves NAD+ salvage and SAM availability Regulatory status: not approved by the FDA or any other regulatory authority